Last I heard - back in March
Had a conversation with investor relations. I've seen absolutely nothing since. Haven't called, either. Out of curiosity I just tried and the IR folks phone number from the website now responds as "not in service." No SEC filings since last year, other than the notice of inability to timely file. At that time good progress was made on the trials, from a medical standpoint, but had burned through so much cash they needed funds and were in conversations with possible partners, sources, etc. Market might have weakened around them by some other study announcements that stents in general may be less desirable than they had been previously thought.
News 
Market Data 
Discover 
